Safety of nitrous oxide administration in patients with Charcot-Marie-Tooth disease
Introduction
Charcot-Marie-Tooth disease (CMT) in all its forms is the most common inherited peripheral neuropathy in humans, with a total prevalence rate of 1 in 2500 [1]. A list of potential medications to avoid in CMT is maintained by the CMT Association (USA), CMT Association of Australia, CMT International (Canada) and CMT United Kingdom. In particular, nitrous oxide used in children and adults as an anaesthetic for procedures such as nerve conduction studies and maintenance for general anaesthesia is cited as a ‘moderate to significant’ risk of potential toxicity and worsening neuropathy in people with CMT. This is also stated in a recent literature review and analysis of the CMT North American Database (209 respondents) whereby nitrous oxide exposure was reported to exacerbate CMT-related neuropathy in three of six cases (50% of reported exposures) [2].
While the ‘Medical Alert’ on the CMT Association (USA) website (http://www.charcot-marie-tooth.org/med_alert.php) cautions nitrous oxide use, especially with inhalation abuse leading to Vitamin B12 deficiency, it is unclear as to the level of risk in others with CMT where there is far less exposure. Since these ‘Medical Alert’ lists are commonly accessed by patients, treating physicians and the public to assess risk of medication-induced side effects in CMT, we performed a systematic review of the literature focussing on the use of nitrous oxide in patients with CMT to help clarify its safety.
Section snippets
Methods
We performed an Ovid literature search of the databases PREMEDLINE, MEDLINE (January 1966 to October 2007) and EMBASE (January 1980 to October 2007). The search strategy was refined by using various permutations of the terms “Charcot Marie Tooth Disease” or “Hereditary Motor Sensory Neuropathy” and included the keyword “nitrous”. The search was not restricted in language or type of study. All abstracts were reviewed and full text articles were obtained for all studies that reported the use of
Results
The initial literature review identified 28 papers (including the study by Weimer and Podwall [2]) of which 11 reported the use of inhaled nitrous oxide in patients with CMT [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15]. An additional two papers were identified from reference lists [16], [17] which provided less specific information on general anaesthesia in CMT patients. The initial 11 papers were mainly individual cases and two small case series. In the two case series the
Discussion
We were unable to find any reports of worsening of CMT neuropathy associated with therapeutically inhaled nitrous oxide. Weimer and Podwall were also unable to identify any cases of worsening of CMT neuropathy with nitrous oxide in their literature search [2]. However, they only searched for positive cases of nitrous oxide exposure and worsening of neuropathic symptoms in CMT and only searched the MEDLINE database. Weimer and Podwall [2] investigated the relationship between a number of
References (19)
- et al.
Medication-induced exacerbation of neuropathy in Charcot Marie Tooth Disease
J Neurol Sci
(2006) - et al.
Prolonged vecuronium neuromuscular blockade associated with Charcot Marie Tooth neuropathy
Br J Anaesth
(2000) - et al.
Nitrous oxide use in first-year students at Auckland University
Lancet
(2003) Genetic and clinical aspects of Charcot-Marie-Tooth disease
Clin Genet
(1974)- et al.
Textbook of adverse drug reactions
(1998) Meyler's side effects of drugs: the international encyclopedia of adverse drug reactions and interactions
(2006)Vecuronium neuromuscular block in a patient with Charcot-Marie-Tooth syndrome
Anesth Analg
(1997)- et al.
Anesthetic management for cesarean section of a patient with Charcot-Marie-Tooth disease
Anesthesiology
(1987) - et al.
Anaesthetic management for arthrodesis of a patient with Charcot-Marie-Tooth disease. A case report
Anest Rianim
(1988)
Cited by (9)
Anesthetic considerations in Charcot-Marie-Tooth disease
2011, Revista Espanola de Anestesiologia y ReanimacionToxic medications in Charcot–Marie–Tooth patients: A systematic review
2023, Journal of the Peripheral Nervous SystemOrphanAnesthesia – Recommendation for the anaesthesiological management of patients with amylotrophic lateral sclerosis and Charcot-Marie-Tooth disease
2022, Anasthesiologie und IntensivmedizinUnderstanding medication safety and Charcot-Marie-Tooth disease: a patient perspective
2020, International Journal of Clinical PharmacyEnlarged brachial plexus nerve found during ultrasound-guided peripheral nerve block diagnosed as charcot-marie-tooth disease: A case report
2020, Local and Regional AnesthesiaCharcot-marie-tooth
2018, Consults in Obstetric Anesthesiology